Trial NCT04044651

View at ClinicalTrials.gov 
Org. Study IDs: HCC-S051

Last trial update was posted on 2020-01-09

MeSH Interventions

Lenvatinib Nivolumab

MeSH Conditions

Carcinoma Carcinoma, Hepatocellular Hepatitis Hepatitis B

Other Conditions

Hepatocellular Carcinoma

Stopping Reasons

Bristol-Myers Squibb company terminated this study

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID